Lane, H.C. et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309, 453–458 (1983).

Article  CAS  Google Scholar 

Hellerstein, M. et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5, 83–89 (1999).

Article  CAS  Google Scholar 

Hazenberg, M.D. et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95, 249–255 (2000).

CAS  PubMed  Google Scholar 

Valdez, H. & Lederman, M.M. Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev. 187–228 (1997).

Giorgi, J.V. et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859–870 (1999).

Article  CAS  Google Scholar 

Brenchley, J.M., Price, D.A. & Douek, D.C. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7, 235–239 (2006).

Article  CAS  Google Scholar 

Grossman, Z., Meier-Schellersheim, M., Paul, W.E. & Picker, L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12, 289–295 (2006).

Article  CAS  Google Scholar 

Mattapallil, J.J. et al. Massive infection and loss of memory CD4⁺ T cells in multiple tissues during acute SIV infection. Nature 434, 1093–1097 (2005).

Article  CAS  Google Scholar 

Veazey, R.S. et al. Gastrointestinal tract as a major site of CD4⁺ T cell depletion and viral replication in SIV infection. Science 280, 427–431 (1998).

Article  CAS  Google Scholar 

Guadalupe, M. et al. Severe CD4⁺ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708–11717 (2003).

Article  CAS  Google Scholar 

Brenchley, J.M. et al. CD4⁺ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749–759 (2004).

Article  CAS  Google Scholar 

Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4⁺ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761–770 (2004).

Article  CAS  Google Scholar 

Picker, L.J. et al. Insufficient production and tissue delivery of CD4⁺ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200, 1299–1314 (2004).

Article  CAS  Google Scholar 

George, M.D., Reay, E., Sankaran, S. & Dandekar, S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4⁺ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J. Virol. 79, 2709–2719 (2005).

Article  CAS  Google Scholar 

Kotler, D.P. HIV infection and the gastrointestinal tract. AIDS 19, 107–117 (2005).

Article  Google Scholar 

Sharpstone, D. et al. Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut 45, 70–76 (1999).

Article  CAS  Google Scholar 

Macpherson, A.J. & Harris, N.L. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478–485 (2004).

Article  CAS  Google Scholar 

Cooke, K.R., Olkiewicz, K., Erickson, N. & Ferrara, J.L. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J. Endotoxin Res. 8, 441–448 (2002).

Article  CAS  Google Scholar 

Caradonna, L. et al. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6, 205–214 (2000).

CAS  PubMed  Google Scholar 

Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003).

Article  CAS  Google Scholar 

Hill, G.R. et al. Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia. J. Clin. Invest. 104, 459–467 (1999).

Article  CAS  Google Scholar 

Schietroma, M. et al. Intestinal and systemic endotoxaemia after laparotomic or laparoscopic cholecystectomy. Chir. Ital. 58, 171–177 (2006).

PubMed  Google Scholar 

Wellmann, W., Fink, P.C., Benner, F. & Schmidt, F.W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 27, 814–820 (1986).

Article  CAS  Google Scholar 

Wyatt, J., Vogelsang, H., Hubl, W., Waldhoer, T. & Lochs, H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341, 1437–1439 (1993).

Article  CAS  Google Scholar 

Schietroma, M., Carlei, F., Cappelli, S. & Amicucci, G. Intestinal permeability and systemic endotoxemia after laparotomic or laparoscopic cholecystectomy. Ann. Surg. 243, 359–363 (2006).

Article  Google Scholar 

Kitchens, R.L. & Thompson, P.A. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J. Endotoxin Res. 11, 225–229 (2005).

Article  CAS  Google Scholar 

Lien, E. et al. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92, 2084–2092 (1998).

CAS  PubMed  Google Scholar 

Nomura, F. et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 164, 3476–3479 (2000).

Article  CAS  Google Scholar 

Strutz, F., Heller, G., Krasemann, K., Krone, B. & Muller, G.A. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med. 25, 435–444 (1999).

Article  CAS  Google Scholar 

Cohen, I.R. & Norins, L.C. Natural human antibodies to gram-negative bacteria: immunoglobulins G, A, and M. Science 152, 1257–1259 (1966).

Article  CAS  Google Scholar 

Barclay, G.R. Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog. Clin. Biol. Res. 392, 263–272 (1995).

CAS  PubMed  Google Scholar 

Titanji, K. et al. Loss of memory B cells impairs maintenance of long-term serological memory during HIV-1 infection. Blood 108, 1580–1587 (2006).

Article  CAS  Google Scholar 

Ito, T., Kanzler, H., Duramad, O., Cao, W. & Liu, Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107, 2423–2431 (2006).

Article  CAS  Google Scholar 

Aziz, N. et al. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. J. Infect. Dis. 179, 843–848 (1999).

Article  CAS  Google Scholar 

Haas, D.W. et al. Proinflammatory cytokine and human immunodeficiency virus RNA levels during early Mycobacterium avium complex bacteremia in advanced AIDS. J. Infect. Dis. 177, 1746–1749 (1998).

Article  CAS  Google Scholar 

MacArthur, R.D. et al. Effects of mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853. J. Infect. Dis. 181, 1486–1490 (2000).

Article  CAS  Google Scholar 

Beignon, A.S. et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115, 3265–3275 (2005).

Article  CAS  Google Scholar 

Caron, G. et al. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4⁺ T cells. J. Immunol. 175, 1551–1557 (2005).

Article  CAS  Google Scholar 

Kovacs, J.A. et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194, 1731–1741 (2001).

Article  CAS  Google Scholar 

Lederman, M.M. et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS clinical trials group protocol 315. J. Infect. Dis. 178, 70–79 (1998).

Article  CAS  Google Scholar 

Bafica, A., Scanga, C.A., Schito, M., Chaussabel, D. & Sher, A. Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J. Immunol. 172, 7229–7234 (2004).

Article  CAS  Google Scholar 

Morris, L. et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188, 233–245 (1998).

Article  CAS  Google Scholar 

Emu, B. et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 79, 14169–14178 (2005).

Article  CAS  Google Scholar 

Holmes, C.L., Russell, J.A. & Walley, K.R. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124, 1103–1115 (2003).

Article  CAS  Google Scholar 

Sankaran, S. et al. Gut mucosal T cell responses and gene expression correlate with protection against disease in long-term HIV-1-infected nonprogressors. Proc. Natl. Acad. Sci. USA 102, 9860–9865 (2005).

Article  CAS  Google Scholar 

Silvestri, G. et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441–452 (2003).

Article  CAS  Google Scholar 

Zaunders, J.J. et al. Increased turnover of CCR5⁺ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 183, 736–743 (2001).

Article  CAS  Google Scholar 

Skoner, D.P., Gentile, D.A., Patel, A. & Doyle, W.J. Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J. Infect. Dis. 180, 10–14 (1999).

Article  CAS  Google Scholar 

Veazey, R.S. et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438, 99–102 (2005).

Article  CAS  Google Scholar 

Fort, M.M. et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J. Immunol. 174, 6416–6423 (2005).

Article  CAS  Google Scholar